The share of Germany's scientific publications in the world's top 10% most-cited drug discovery papers is forecasted to grow steadily from 15.51% in 2024 to 16.87% by 2028. In 2023, Germany's share stood at an estimated 15.16%, reflecting an ongoing upward trajectory. The year-on-year variation highlights incremental growth, averaging a constant rise of around 0.35 percentage points annually. The compound annual growth rate (CAGR) points to a consistent increase of approximately 2.2% over five years.
Future trends to watch include the increasing emphasis on interdisciplinary collaborations and the impact of AI and machine learning in enhancing the quality and impact of Germany’s scientific research in drug discovery. The ability to harness these innovations will likely accelerate Germany's contribution to high-impact publications.
